Download Now: 7 Unstoppable Growth Engines of India's $10 Trillion Bull Run...
Here is the latest financial fact sheet of KWALITY PHARMA. For more details, see the KWALITY PHARMA quarterly results and KWALITY PHARMA share price. For a sector overview, read our pharmaceuticals sector report.
1 Day | % | 1.4 |
No. of shares | m | 10.38 |
1 Week | % | 12.9 |
1 Month | % | 21.3 |
1 Year | % | 38.7 |
52 week H/L | Rs | 545.0/248.0 |
No. of Mths Year Ending |
12 Mar-19* |
12 Mar-20* |
12 Mar-21* |
12 Mar-22* |
12 Mar-23* |
5-Yr Chart Click to enlarge
|
---|
KWALITY PHARMA EQUITY SHARE DATA | |||||||
---|---|---|---|---|---|---|---|
High | Rs | 57 | 46 | 71 | 1,117 | 639 | |
Low | Rs | 36 | 21 | 26 | 53 | 266 | |
Sales per share (Unadj.) | Rs | 160.2 | 134.2 | 252.4 | 439.5 | 241.8 | |
Earnings per share (Unadj.) | Rs | 7.3 | 7.9 | 14.3 | 115.5 | 18.6 | |
Diluted earnings per share | Rs | 7.3 | 7.9 | 14.3 | 115.6 | 18.6 | |
Cash flow per share (Unadj.) | Rs | 10.3 | 12.2 | 20.6 | 125.8 | 33.0 | |
Dividends per share (Unadj.) | Rs | 0 | 0 | 0 | 0 | 0 | |
Adj. dividends per share | Rs | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Avg Dividend yield | % | 0 | 0 | 0 | 0 | 0 | |
Book value per share (Unadj.) | Rs | 35.9 | 44.3 | 58.9 | 174.5 | 193.2 | |
Adj. book value per share | Rs | 35.9 | 44.3 | 58.9 | 174.6 | 193.2 | |
Shares outstanding (eoy) | m | 10.38 | 10.38 | 10.38 | 10.38 | 10.38 | |
Price / Sales ratio | x | 0.3 | 0.3 | 0.2 | 1.3 | 1.9 | |
Avg P/E ratio | x | 6.4 | 4.3 | 3.4 | 5.1 | 24.3 | |
P/CF ratio (eoy) | x | 4.5 | 2.8 | 2.3 | 4.6 | 13.7 | |
Price / Book Value ratio | x | 1.3 | 0.8 | 0.8 | 3.4 | 2.3 | |
Dividend payout | % | 0 | 0 | 0 | 0 | 0 | |
Avg Mkt Cap | Rs m | 484 | 349 | 501 | 6,070 | 4,693 | |
Total wages/salary | Rs m | 77 | 109 | 147 | 188 | 282 |
KWALITY PHARMA INCOME DATA | |||||||
---|---|---|---|---|---|---|---|
Net Sales | Rs m | 1,663 | 1,393 | 2,620 | 4,562 | 2,510 | |
Other income | Rs m | 6 | 37 | 16 | 35 | 29 | |
Total revenues | Rs m | 1,669 | 1,430 | 2,636 | 4,597 | 2,540 | |
Gross profit | Rs m | 157 | 142 | 289 | 1,717 | 442 | |
Depreciation | Rs m | 31 | 44 | 65 | 107 | 150 | |
Interest | Rs m | 23 | 25 | 27 | 29 | 66 | |
Profit before tax | Rs m | 109 | 109 | 213 | 1,616 | 256 | |
Minority Interest | Rs m | 0 | 0 | 0 | 0 | 0 | |
Prior Period Items | Rs m | 0 | 0 | 0 | 0 | 0 | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | 0 | 0 | 0 | |
Tax | Rs m | 34 | 27 | 64 | 416 | 63 | |
Profit after tax | Rs m | 76 | 82 | 149 | 1,199 | 193 | |
Gross profit margin | % | 9.4 | 10.2 | 11.0 | 37.6 | 17.6 | |
Effective tax rate | % | 30.7 | 24.8 | 30.0 | 25.8 | 24.6 | |
Net profit margin | % | 4.5 | 5.9 | 5.7 | 26.3 | 7.7 |
KWALITY PHARMA BALANCE SHEET DATA | |||||||
---|---|---|---|---|---|---|---|
Current assets | Rs m | 754 | 890 | 1,059 | 2,278 | 2,072 | |
Current liabilities | Rs m | 608 | 678 | 783 | 1,395 | 1,259 | |
Net working cap to sales | % | 8.7 | 15.3 | 10.5 | 19.4 | 32.4 | |
Current ratio | x | 1.2 | 1.3 | 1.4 | 1.6 | 1.6 | |
Inventory Days | Days | 11 | 11 | 7 | 7 | 17 | |
Debtors Days | Days | 843 | 795 | 497 | 553 | 1,042 | |
Net fixed assets | Rs m | 300 | 435 | 603 | 1,128 | 1,464 | |
Share capital | Rs m | 104 | 104 | 104 | 104 | 104 | |
"Free" reserves | Rs m | 269 | 356 | 508 | 1,708 | 1,901 | |
Net worth | Rs m | 373 | 460 | 612 | 1,811 | 2,005 | |
Long term debt | Rs m | 76 | 102 | 183 | 203 | 273 | |
Total assets | Rs m | 1,054 | 1,325 | 1,662 | 3,406 | 3,536 | |
Interest coverage | x | 5.8 | 5.4 | 9.0 | 56.4 | 4.9 | |
Debt to equity ratio | x | 0.2 | 0.2 | 0.3 | 0.1 | 0.1 | |
Sales to assets ratio | x | 1.6 | 1.1 | 1.6 | 1.3 | 0.7 | |
Return on assets | % | 9.3 | 8.1 | 10.6 | 36.1 | 7.3 | |
Return on equity | % | 20.3 | 17.8 | 24.3 | 66.2 | 9.6 | |
Return on capital | % | 29.4 | 23.9 | 30.2 | 81.7 | 14.1 | |
Exports to sales | % | 0 | 0 | 0 | 0 | 0 | |
Imports to sales | % | 4.6 | 7.5 | 11.2 | 14.3 | 7.5 | |
Exports (fob) | Rs m | 0 | 0 | 0 | 0 | 0 | |
Imports (cif) | Rs m | 76 | 105 | 294 | 651 | 188 | |
Fx inflow | Rs m | 836 | 788 | 1,658 | 2,997 | 1,198 | |
Fx outflow | Rs m | 85 | 118 | 307 | 723 | 287 | |
Net fx | Rs m | 751 | 670 | 1,351 | 2,274 | 911 |
KWALITY PHARMA CASH FLOW | |||||||
---|---|---|---|---|---|---|---|
From Operations | Rs m | 136 | 62 | 267 | 606 | 414 | |
From Investments | Rs m | -118 | -178 | -232 | -629 | -484 | |
From Financial Activity | Rs m | -20 | 118 | 8 | 57 | 10 | |
Net Cashflow | Rs m | -2 | 1 | 43 | 33 | -61 |
Share Holding
Shareholding as on Mar 2024
|
Company Information
|
CHM: Ramesh Arora | COMP SEC: Gurpreet Kaur | YEAR OF INC: 1983 | BSE CODE: 539997 | FV (Rs): 10 | DIV YIELD (%): - |
More Pharmaceuticals Company Fact Sheets: DIVIS LABORATORIES DR. REDDYS LAB ZYDUS LIFESCIENCES CIPLA SUN PHARMA
Compare KWALITY PHARMA With: DIVIS LABORATORIES DR. REDDYS LAB ZYDUS LIFESCIENCES CIPLA SUN PHARMA
After opening the day on high, Indian share markets reversed the trend as the session progressed and ended the lower.